Our results confirm the previously established breast cancer risk-reducing effect of BRRM [15–17] and suggest that the lack of statistical significance in the Danish study from 2010 was likely due to its small sample size of 307 BRCA1/2 carriers [19]. The gene discussed is BRCA1; the disease is breast cancer.